Terumo Revenue 2012-2024 | TRUMY
- Terumo revenue for the quarter ending September 30, 2024 was $M, a 100% decline year-over-year.
- Terumo revenue for the twelve months ending September 30, 2024 was $4.743B, a 13.56% decline year-over-year.
- Terumo annual revenue for 2024 was $6.361B, a 4.8% increase from 2023.
- Terumo annual revenue for 2023 was $6.07B, a 3.03% decline from 2022.
- Terumo annual revenue for 2022 was $6.259B, a 8.48% increase from 2021.
Terumo Annual Revenue (Millions of US $) |
|
---|---|
2024 | $6,361 |
2023 | $6,070 |
2022 | $6,259 |
2021 | $5,770 |
2020 | $5,786 |
2019 | $5,395 |
2018 | $5,290 |
2017 | $4,782 |
2016 | $4,358 |
2015 | $4,476 |
2014 | $4,674 |
2013 | $4,868 |
2012 | $4,911 |
Terumo Quarterly Revenue (Millions of US $) |
|
---|---|
2024-09-30 | |
2024-06-30 | $1,652 |
2023-06-30 | $1,571 |
2022-06-30 | $1,520 |
2021-06-30 | $1,563 |
2020-06-30 | $1,221 |
2019-06-30 | $1,388 |
2018-06-30 | $1,316 |
2017-06-30 | $1,254 |
2016-06-30 | $1,158 |
2015-06-30 | $1,055 |
2015-03-31 | $1,061 |
2014-12-31 | $1,143 |
2014-09-30 | $1,136 |
2014-06-30 | $1,123 |
2014-03-31 | $1,221 |
2013-12-31 | $1,192 |
2013-09-30 | $1,161 |
2013-06-30 | $1,122 |
2013-03-31 | $1,289 |
2012-12-31 | $1,278 |
2012-09-30 | $1,219 |
2012-06-30 | $1,198 |
2012-03-31 | $1,242 |
2011-12-31 | $1,267 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Products Manufacturing | $28.994B | $6.386B |
Terumo Corporation is engaged in the manufacture and sales of medical products and equipment. The products offered by the Company covers General Hospital Products, Cardiac & Vascular Products, Blood Transfusion Products and Consumer Healthcare Products. General hospital products offered by it include Disposable Medical Equipment, Medical Electronic Products, Diabetes Care Products, CAPD Systems and Pharmaceuticals; Cardiac & Vascular Products include Interventional Systems, Cardiovascular Systems and Artificial Vascular Grafts. Terumo's Blood Transfusion products include blood bags, blood filter, filter in line, blood administration sets and apheresis, while consumer healthcare products include ear thermometer, electronic thermometer, basal body thermometer, electronic sphygmomanometer, urine test strip and leg compression stockings. Terumo Corporation is headquartered in Tokyo, Japan. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Abbott Laboratories (ABT) | United States | $199.931B | 25.50 |
Stryker (SYK) | United States | $140.829B | 31.74 |
Boston Scientific (BSX) | United States | $134.782B | 38.75 |
EssilorLuxottica (ESLOY) | France | $111.024B | 0.00 |
Medtronic (MDT) | Ireland | $104.635B | 15.54 |
Haleon (HLN) | United Kingdom | $44.090B | 28.65 |
Lonza Group Ag (LZAGY) | Switzerland | $43.326B | 0.00 |
GE HealthCare Technologies (GEHC) | United States | $36.417B | 18.89 |
ResMed (RMD) | United States | $34.333B | 28.21 |
Koninklijke Philips (PHG) | Netherlands | $24.222B | 18.54 |
Zimmer Biomet Holdings (ZBH) | United States | $21.351B | 13.59 |
Insulet (PODD) | United States | $18.636B | 74.21 |
Baxter (BAX) | United States | $14.960B | 9.73 |
Smith & Nephew SNATS (SNN) | United Kingdom | $10.694B | 0.00 |
BellRing Brands (BRBR) | United States | $9.888B | 39.78 |
Bio-Rad Laboratories (BIO) | United States | $9.278B | 31.53 |
Demant (WILYY) | Denmark | $8.092B | 0.00 |
Lantheus Holdings (LNTH) | United States | $6.483B | 15.06 |
Haemonetics (HAE) | United States | $3.960B | 19.33 |
Prestige Consumer Healthcare (PBH) | United States | $3.914B | 19.47 |
ICU Medical (ICUI) | United States | $3.831B | 36.47 |
Perrigo (PRGO) | Ireland | $3.548B | 10.45 |
Envista Holdings (NVST) | United States | $3.328B | 24.80 |
Shandong Weigao Medical Polymer (SHWGF) | China | $3.010B | 0.00 |
QuidelOrtho (QDEL) | United States | $3.000B | 19.31 |
GN Store Nord (GNNDY) | Denmark | $2.779B | 17.82 |
Neogen (NEOG) | United States | $2.694B | 31.08 |
LeMaitre Vascular (LMAT) | United States | $2.114B | 51.39 |
Green Thumb Industries (GTBIF) | United States | $1.638B | 28.67 |
AtriCure (ATRC) | United States | $1.499B | 0.00 |
InMode (INMD) | Israel | $1.453B | 8.74 |
Maravai LifeSciences Holdings (MRVI) | United States | $1.417B | 0.00 |
AdaptHealth (AHCO) | United States | $1.317B | 9.41 |
BioLife Solutions (BLFS) | United States | $1.254B | 0.00 |
Curaleaf Holdings (CURLF) | Canada | $1.014B | 0.00 |
Owens & Minor (OMI) | United States | $1.000B | 7.81 |
CeriBell (CBLL) | United States | $0.949B | 0.00 |
Phibro Animal Health (PAHC) | United States | $0.878B | 15.49 |
Evolus (EOLS) | United States | $0.719B | 0.00 |
Capricor Therapeutics (CAPR) | United States | $0.640B | 0.00 |
VAREX IMAGING (VREX) | United States | $0.621B | 27.40 |
Omeros (OMER) | United States | $0.606B | 0.00 |
Surmodics (SRDX) | United States | $0.567B | 0.00 |
Verano Holdings (VRNOF) | United States | $0.438B | 0.00 |
Quanterix (QTRX) | United States | $0.425B | 0.00 |
Cresco Labs (CRLBF) | United States | $0.414B | 0.00 |
ZimVie (ZIMV) | United States | $0.389B | 32.81 |
Valneva SE (VALN) | France | $0.341B | 0.00 |
Biote (BTMD) | United States | $0.335B | 7.35 |
Viemed Healthcare (VMD) | United States | $0.318B | 30.26 |
Canopy Growth (CGC) | Canada | $0.309B | 0.00 |
Cerus (CERS) | United States | $0.308B | 0.00 |
Sanara MedTech (SMTI) | United States | $0.299B | 0.00 |
OraSure Technologies (OSUR) | United States | $0.272B | 18.20 |
Zynex (ZYXI) | United States | $0.265B | 55.47 |
High Tide (HITI) | Canada | $0.259B | 107.33 |
Aurora Cannabis (ACB) | Canada | $0.238B | 0.00 |
Utah Medical Products (UTMD) | United States | $0.209B | 14.42 |
MacroGenics (MGNX) | United States | $0.205B | 0.00 |
Organigram Holdings (OGI) | Canada | $0.201B | 0.00 |
Sanuwave Health (SNWV) | United States | $0.194B | 2.73 |
Jin Medical (ZJYL) | China | $0.186B | 0.00 |
TerrAscend (TSNDF) | Canada | $0.184B | 0.00 |
Brainsway (BWAY) | Israel | $0.176B | 93.70 |
TriSalus Life Sciences (TLSI) | United States | $0.152B | 0.00 |
FitLife Brands (FTLF) | United States | $0.148B | 18.58 |
Quipt Home Medical (QIPT) | United States | $0.108B | 0.00 |
Veru (VERU) | United States | $0.100B | 0.00 |
Fonar (FONR) | United States | $0.097B | 10.93 |
Oramed Pharmaceuticals (ORMP) | United States | $0.095B | 0.00 |
Exagen (XGN) | United States | $0.089B | 0.00 |
InterCure (INCR) | Israel | $0.077B | 0.00 |
Rockwell Medical (RMTI) | United States | $0.070B | 36.00 |
Apyx Medical (APYX) | United States | $0.060B | 0.00 |
Jushi Holdings (JUSHF) | United States | $0.054B | 0.00 |
Modular Medical (MODD) | United States | $0.049B | 0.00 |
Cytosorbents (CTSO) | United States | $0.049B | 0.00 |
Safety Shot (SHOT) | United States | $0.048B | 0.00 |
ImmuCell (ICCC) | United States | $0.042B | 0.00 |
Allurion Technologies (ALUR) | United States | $0.028B | 0.00 |
Flora Growth (FLGC) | United States | $0.016B | 0.00 |
Nephros (NEPH) | United States | $0.016B | 0.00 |
Innovative Eyewear (LUCY) | United States | $0.014B | 0.00 |
Cellectar Biosciences (CLRB) | United States | $0.013B | 0.00 |
Meihua Medical Technologies (MHUA) | China | $0.009B | 0.00 |
NeuroMetrix (NURO) | United States | $0.008B | 0.00 |
Trinity Biotech (TRIB) | Ireland | $0.006B | 0.00 |
IM Cannabis (IMCC) | Canada | $0.005B | 0.00 |
Leafly Holdings (LFLY) | United States | $0.005B | 0.00 |
Agape ATP (ATPC) | $0.005B | 0.00 | |
GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
Sharps Technology (STSS) | United States | $0.004B | 0.00 |
Senestech (SNES) | United States | $0.003B | 0.00 |
Akanda (AKAN) | United Kingdom | $0.002B | 0.00 |
InVivo Therapeutics Holdings (NVIVQ) | United States | $0.001B | 0.00 |
United-Guardian (UG) | United States | $0.000B | 12.81 |
SNDL (SNDL) | Canada | $0.000B | 0.00 |